Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML

NCT03661515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Selinexor
DRUG: fludarabine
DRUG: idarubicin
DRUG: cytarabine
DRUG: G-CSF

Sponsor

PETHEMA Foundation